Literature DB >> 32328385

Stevens-Johnson Syndrome: A Perplexing Diagnosis.

Jonathan Dutt1, Amit Sapra2, Pooja Sheth-Dutt1, Priyanka Bhandari2, Supriya Gupta1.   

Abstract

Stevens-Johnson syndrome/toxic epidermal necrolysis is a spectrum of mucocutaneous reactions that can occur due to drug reactions, infections with Mycoplasma pneumonia, human immunodeficiency virus (HIV), cancer, and genetics. Stevens-Johnson syndrome involves less than 10% of the body surface, while toxic epidermal necrolysis involves greater than 30%. The most common site of the lesions is mucocutaneous surfaces such as the eyes and oral cavity. Our patient was a 44-year-old female who presented to the emergency department with concerns for pain in her eyes, hands and feet, rash, and sore throat. Her rash worsened during the initial hospitalization. This case emphasizes the importance of pattern recognition of Stevens-Johnson syndrome, as this is a rare but serious condition that must be recognized and treated appropriately. The reaction is most commonly due to medications; however, a thorough history and physical exam are vital to diagnosing this potentially fatal condition.
Copyright © 2020, Dutt et al.

Entities:  

Keywords:  conjunctivitis; drug rash; drug reaction; fever; sepsis; skin biopsy; skin rash; stevens-johnson syndrome; toxic epidermal necrolysis

Year:  2020        PMID: 32328385      PMCID: PMC7176330          DOI: 10.7759/cureus.7374

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  9 in total

1.  The role of systemic corticosteroid therapy in erythema multiforme major and stevens-johnson syndrome: a review of past and current opinions.

Authors:  Brent Michaels
Journal:  J Clin Aesthet Dermatol       Date:  2009-03

Review 2.  [News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)].

Authors:  Sylvia Aide Martínez-Cabriales; Minerva Gómez-Flores; Jorge Ocampo-Candiani
Journal:  Gac Med Mex       Date:  2015 Nov-Dec       Impact factor: 0.302

3.  Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  James W Antoon; Jennifer L Goldman; Brian Lee; Alan Schwartz
Journal:  Pediatr Dermatol       Date:  2018-01-09       Impact factor: 1.588

4.  Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Ariana Eginli; Kena Shah; Casey Watkins; Guha Krishnaswamy
Journal:  Ann Allergy Asthma Immunol       Date:  2017-02       Impact factor: 6.347

Review 5.  Adverse drug reactions.

Authors:  Zachary Seagrave; Sonya Bamba
Journal:  Dis Mon       Date:  2016-12-27       Impact factor: 3.800

Review 6.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update.

Authors:  Roni P Dodiuk-Gad; Wen-Hung Chung; Laurence Valeyrie-Allanore; Neil H Shear
Journal:  Am J Clin Dermatol       Date:  2015-12       Impact factor: 7.403

Review 7.  Stevens-Johnson syndrome and toxic epidermal necrolysis: a review.

Authors:  Anthony Wong; Andrey Augusto Malvestiti; Mariana de Figueiredo Silva Hafner
Journal:  Rev Assoc Med Bras (1992)       Date:  2016 Sep-Oct       Impact factor: 1.209

8.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Elizabeth Noble Ergen; Lauren C Hughey
Journal:  JAMA Dermatol       Date:  2017-12-01       Impact factor: 10.282

Review 9.  Toxic epidermal necrolysis and Stevens-Johnson syndrome.

Authors:  Thomas Harr; Lars E French
Journal:  Orphanet J Rare Dis       Date:  2010-12-16       Impact factor: 4.123

  9 in total
  3 in total

1.  Early Diagnosis of Stevens-Johnson Syndrome in the Dental Clinic Setting.

Authors:  Wisam K Al Hathlol; Asma Almeslet
Journal:  Cureus       Date:  2021-03-28

2.  Concomitance or consequence? Stevens-Johnson syndrome in COVID-19: A case report.

Authors:  Carmen Manciuc; Georgiana Alexandra Lacatusu; Andrei Vata; Cristina Sapaniuc; Carmen Mihaela Arteni; Florin Dumitru Petrariu
Journal:  Exp Ther Med       Date:  2022-02-02       Impact factor: 2.447

3.  Stevens-Johnson Syndrome in a Patient of Color: A Case Report and an Assessment of Diversity in Medical Education Resources.

Authors:  Darlene Diep; Bineetha Aluri; Alison Crane; Kathleen Miao; Kamilah S Kannan; Robert Goldsteen
Journal:  Cureus       Date:  2022-02-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.